ATIM-19. CATEGORIZING IMMUNE RESPONDERS WITH FUSION METRICS AND SIMULATION FOR ASSOCIATION TO SURVIVAL AND PROGRESSION FREE SURVIVAL WITH IMMUNE RESPONSE IN HLA-A2+ PATIENTS WITH GBM FROM A PHASE 2 TRIAL OF DENDRITIC CELL (DC) IMMUNOTHERAPY (ICT-107) Article

Santos, Radleigh, Pinilla, Clemencia, Swanson, Steven J et al. (2016). ATIM-19. CATEGORIZING IMMUNE RESPONDERS WITH FUSION METRICS AND SIMULATION FOR ASSOCIATION TO SURVIVAL AND PROGRESSION FREE SURVIVAL WITH IMMUNE RESPONSE IN HLA-A2+ PATIENTS WITH GBM FROM A PHASE 2 TRIAL OF DENDRITIC CELL (DC) IMMUNOTHERAPY (ICT-107) . NEURO-ONCOLOGY, 18(suppl_6), vi22-vi22. 10.1093/neuonc/now212.084

cited authors

  • Santos, Radleigh; Pinilla, Clemencia; Swanson, Steven J; Gringeri, Anthony; Yu, John

authors

publication date

  • November 1, 2016

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3204 Immunology
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Health Disparities
  • Immunization
  • Inflammatory and immune system
  • Minority Health
  • Vaccine Related

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi22

end page

  • vi22

volume

  • 18

issue

  • suppl_6